BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1478132)

  • 1. [Serum concentrations of amitriptyline and its metabolites and clinical effect in depressive patients].
    Zhang X
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Aug; 25(4):196-8, 252. PubMed ID: 1478132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels and response to amitriptyline in depressed out-patients.
    Rowan PR; Paykel ES; Marks V; Mould G; Bhat A
    Neuropsychobiology; 1984; 12(1):9-15. PubMed ID: 6514181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation of plasma amitriptyline and nortriptyline levels to the therapeutic response in endogenous depression].
    Garaj V; Frank V; Drímalová M; Móric R; Pullmann R
    Cesk Psychiatr; 1986 Oct; 82(5):307-12. PubMed ID: 3791462
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
    Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J
    J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
    Monteleone P; Fabrazzo M
    Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.
    Jungkunz G; Kuss HJ
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):111-6. PubMed ID: 7393997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients.
    Robinson DS; Cooper TB; Howard D; Corcella J; Albright D
    J Clin Psychopharmacol; 1985 Apr; 5(2):83-8. PubMed ID: 3988974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
    Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
    Vandel S; Bertschy G; Jounet JM; Allers G
    Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response and plasma concentrations of amitriptyline and its metabolite-nortriptyline in depressive patients.
    Miljković B; Pokrajac M; Timotijević I; Varagić V
    Eur J Drug Metab Pharmacokinet; 1996; 21(3):251-5. PubMed ID: 8980924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating delusional depressives with amitriptyline.
    Spiker DG; Dealy RS; Hanin I; Weiss JC; Kupfer DJ
    J Clin Psychiatry; 1986 May; 47(5):243-6. PubMed ID: 3516978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation of plasma levels and clinical response to amitriptyline in treating endogenous depression].
    Liu P
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):263-6, 318. PubMed ID: 3234157
    [No Abstract]   [Full Text] [Related]  

  • 14. Single dose prediction of steady state plasma levels of amitriptyline.
    Madakasira S; Preskorn SH; Weller R; Pardo M
    J Clin Psychopharmacol; 1982 Apr; 2(2):136-9. PubMed ID: 7076879
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study].
    Schnyder C; Baumann P; Jonzier-Perey M; Koeb L; Wertheimer J
    Schweiz Med Wochenschr; 1985 Aug; 115(33):1128-34. PubMed ID: 4035330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state plasma levels during antidepressant therapy with amitriptyline and amitriptylinoxide.
    Koch H
    Isr J Psychiatry Relat Sci; 1990; 27(1):48-56. PubMed ID: 2194992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
    Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
    J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Zerbi F; Savoldi F
    Psychopharmacology (Berl); 1990; 100(3):334-8. PubMed ID: 2315430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of amitriptyline: effect of age and sex.
    Preskorn SH; Mac DS
    J Clin Psychiatry; 1985 Jul; 46(7):276-7. PubMed ID: 4008451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
    Lehmann LS; Bowden CL; Redmond FC; Stanton BC
    Psychopharmacology (Berl); 1982; 77(2):193-7. PubMed ID: 6812139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.